Alx Oncology outlines interim ASPEN-09 data from ~80 patients by mid-2027 as CD47-high cohort shows 22-month median PFS (NASDAQ:ALXO)
Earnings Call Insights: ALX Oncology (ALXO) Q1 2026 Management view Seeking Alpha's Disclaimer: This article was automatically generated by an ...
